11
Aug

After making international headlines with the West’s first approval for a gene therapy, pioneering biotech uniQure is working to flesh out its pipeline of one-time treatments, buying into an early-stage shot at heart failure that could put its technology on the biggest stage yet.

…read more

Source: UniQure bets on a gene therapy for heart failure

    

0 No comments